Reported Earnings • May 16
First quarter 2026 earnings released: NT$0.02 loss per share (vs NT$0.70 profit in 1Q 2025) First quarter 2026 results: NT$0.02 loss per share (down from NT$0.70 profit in 1Q 2025). Revenue: NT$620.2m (up 96% from 1Q 2025). Net loss: NT$3.65m (down 103% from profit in 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. New Risk • May 15
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 1.5% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (NT$2.36b market cap, or US$74.9m). Reported Earnings • Mar 14
Full year 2025 earnings released: NT$0.54 loss per share (vs NT$0.38 profit in FY 2024) Full year 2025 results: NT$0.54 loss per share (down from NT$0.38 profit in FY 2024). Revenue: NT$1.53b (up 85% from FY 2024). Net loss: NT$95.5m (down 247% from profit in FY 2024). Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Annuncio • Mar 12
U-Best Innovative Technology Co., Ltd., Annual General Meeting, Jun 10, 2026 U-Best Innovative Technology Co., Ltd., Annual General Meeting, Jun 10, 2026. Location: 4 floor no,250, sec.2 yung hua rd., an ping district, tainan city Taiwan Annuncio • Jan 03
U-Best Innovative Technology Co., Ltd. Announces Settlement of Civil Litigation Case U-Best Innovative Technology Co., Ltd. announced settlement of Civil Litigation Case. Parties to the legal matter: Plaintiff: Pei-Hsuan Tsai; Defendant: U-BEST INNOVATIVE TECHNOLOGY CO., LTD. Name of the court or punishing agency of the legal matter: Tainan District Court; Reference/Case number of relevant documents of the legal matter: 2025, Refiled Civil Case No. 140; Date of occurrence of the event: September 22, 2025; Details of occurrence (including the matter under dispute): Due to a neighborhood dispute related to company's Liujin Construction Project,company received a civil complaint filed by a neighboring resident, Ms. Tsai, Pei-Hsuan, on the morning of May 7, 2025, seeking compensation for damages. Handling procedure: The Company negotiated with the plaintiff and executed a settlement agreement. Impact on the Company's finance and business and projected amount: There is no material impact on the Company's financial condition or business operations. As the settlement amount is in the form of a real estate purchase, no actual loss has been incurred. Countermeasures and improvement status: The Company and Ms. Pei-Hsuan Tsai entered into a settlement agreement on September 22, 2025, whereby both parties agreed to settle the case for TWD 37 million. The settlement amount will be paid in accordance with the real estate purchase transaction process. Both parties also agreed to separately execute a real estate sale and purchase agreement, which was signed on October 23, 2025. New Risk • Nov 30
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 243% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (NT$2.92b market cap, or US$93.0m). Upcoming Dividend • Nov 26
Upcoming dividend of NT$0.20 per share Eligible shareholders must have bought the stock before 03 December 2025. Payment date: 31 December 2025. Payout ratio is a comfortable 22% but the company is not cash flow positive. Trailing yield: 1.2%. Lower than top quartile of Taiwanese dividend payers (5.5%). Lower than average of industry peers (2.6%). New Risk • Nov 14
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: NT$3.06b (US$98.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company. Reported Earnings • Nov 13
Third quarter 2025 earnings released: EPS: NT$0.53 (vs NT$0.082 loss in 3Q 2024) Third quarter 2025 results: EPS: NT$0.53 (up from NT$0.082 loss in 3Q 2024). Revenue: NT$386.6m (up 85% from 3Q 2024). Net income: NT$94.2m (up NT$107.1m from 3Q 2024). Profit margin: 24% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Sep 08
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to NT$21.80, the stock trades at a trailing P/E ratio of 67.4x. Average trailing P/E is 26x in the Chemicals industry in Taiwan. Total returns to shareholders of 76% over the past three years. New Risk • Sep 01
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: NT$3.05b (US$99.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (26% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (4.9% net profit margin). Market cap is less than US$100m (NT$3.05b market cap, or US$99.3m). Reported Earnings • Aug 17
Second quarter 2025 earnings released: NT$0.53 loss per share (vs NT$0.32 loss in 2Q 2024) Second quarter 2025 results: NT$0.53 loss per share (further deteriorated from NT$0.32 loss in 2Q 2024). Revenue: NT$356.0m (up 102% from 2Q 2024). Net loss: NT$94.1m (loss widened 77% from 2Q 2024). Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Reported Earnings • May 14
First quarter 2025 earnings released: EPS: NT$0.71 (vs NT$0.59 in 1Q 2024) First quarter 2025 results: EPS: NT$0.71 (up from NT$0.59 in 1Q 2024). Revenue: NT$316.5m (up 108% from 1Q 2024). Net income: NT$125.4m (up 37% from 1Q 2024). Profit margin: 40% (down from 60% in 1Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Annuncio • May 03
U-Best Innovative Technology Co., Ltd. to Report Q1, 2025 Results on May 12, 2025 U-Best Innovative Technology Co., Ltd. announced that they will report Q1, 2025 results on May 12, 2025 Valuation Update With 7 Day Price Move • Apr 08
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to NT$14.15, the stock trades at a trailing P/E ratio of 38.7x. Average trailing P/E is 18x in the Chemicals industry in Taiwan. Total returns to shareholders of 8.2% over the past three years. New Risk • Mar 31
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (30% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (6.0% average weekly change). Shareholders have been diluted in the past year (27% increase in shares outstanding). Market cap is less than US$100m (NT$2.96b market cap, or US$89.1m). Reported Earnings • Mar 19
Full year 2024 earnings released: EPS: NT$0.38 (vs NT$0.14 in FY 2023) Full year 2024 results: EPS: NT$0.38 (up from NT$0.14 in FY 2023). Revenue: NT$825.8m (up 60% from FY 2023). Net income: NT$64.9m (up 227% from FY 2023). Profit margin: 7.9% (up from 3.9% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Annuncio • Mar 14
U-Best Innovative Technology Co., Ltd., Annual General Meeting, May 28, 2025 U-Best Innovative Technology Co., Ltd., Annual General Meeting, May 28, 2025, at 09:00 Taipei Standard Time. Location: 4 floor no,250, sec.2 yung hua rd., an ping district, tainan city Taiwan Annuncio • Mar 04
U-Best Innovative Technology Co., Ltd. to Report Fiscal Year 2024 Results on Mar 11, 2025 U-Best Innovative Technology Co., Ltd. announced that they will report fiscal year 2024 results on Mar 11, 2025 Annuncio • Dec 28
U-Best Innovative Technology Co., Ltd. Announces Change of the Financial Officer, Effective January 1, 2025 U-Best Innovative Technology Co., Ltd. announced that name, title, and resume of the previous position holder: CHAO,YING-CHU/Associate Manager of the Finance and Accounting Department of the Company. Name, title, and resume of the new position holder: CHAO,SHANG-WEI/Section Chief of the Finance and Accounting Department of the Company. Effective date is January 1, 2025. Reason for the change: Position adjustment. Reported Earnings • Nov 19
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Third quarter 2024 results: NT$0.08 loss per share (further deteriorated from NT$0.038 loss in 3Q 2023). Revenue: NT$208.8m (up 76% from 3Q 2023). Net loss: NT$13.0m (loss widened 149% from 3Q 2023). Revenue missed analyst estimates by 73%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 4.7% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Annuncio • Nov 05
U-Best Innovative Technology Co., Ltd. to Report Q3, 2024 Results on Nov 12, 2024 U-Best Innovative Technology Co., Ltd. announced that they will report Q3, 2024 results on Nov 12, 2024 New Risk • Oct 30
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: NT$3.21b (US$100.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 53% per year for the foreseeable future. Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Large one-off items impacting financial results. Shareholders have been diluted in the past year (24% increase in shares outstanding). Market cap is less than US$100m (NT$3.21b market cap, or US$100.0m). New Risk • Aug 26
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 505% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 53% per year for the foreseeable future. Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Large one-off items impacting financial results. Shareholders have been diluted in the past year (27% increase in shares outstanding). Market cap is less than US$100m (NT$3.19b market cap, or US$100.0m). Reported Earnings • Aug 15
Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Second quarter 2024 results: NT$0.32 loss per share (down from NT$0.01 profit in 2Q 2023). Revenue: NT$176.4m (up 70% from 2Q 2023). Net loss: NT$53.1m (down NT$54.4m from profit in 2Q 2023). Revenue exceeded analyst estimates by 10%. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 31% p.a. on average during the next 2 years, compared to a 4.7% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 16% per year. Annuncio • Aug 03
U-Best Innovative Technology Co., Ltd. to Report Q2, 2024 Results on Aug 12, 2024 U-Best Innovative Technology Co., Ltd. announced that they will report Q2, 2024 results on Aug 12, 2024 New Risk • Jul 29
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: NT$3.28b (US$99.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 70% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (23% increase in shares outstanding). Market cap is less than US$100m (NT$3.28b market cap, or US$99.9m). Annuncio • May 03
U-Best Innovative Technology Co., Ltd. to Report Q1, 2024 Results on May 09, 2024 U-Best Innovative Technology Co., Ltd. announced that they will report Q1, 2024 results on May 09, 2024 New Risk • Apr 05
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.9% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 55% per year over the past 5 years. Minor Risk Shareholders have been diluted in the past year (3.9% increase in shares outstanding). Reported Earnings • Mar 17
Full year 2023 earnings released: EPS: NT$0.14 (vs NT$0.38 loss in FY 2022) Full year 2023 results: EPS: NT$0.14 (up from NT$0.38 loss in FY 2022). Revenue: NT$516.5m (down 42% from FY 2022). Net income: NT$19.9m (up NT$72.7m from FY 2022). Profit margin: 3.9% (up from net loss in FY 2022). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has increased by 25% per year, which means it is well ahead of earnings. Annuncio • Mar 15
U-Best Innovative Technology Co., Ltd., Annual General Meeting, May 31, 2024 U-Best Innovative Technology Co., Ltd., Annual General Meeting, May 31, 2024. New Risk • Feb 15
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 5.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Earnings have declined by 58% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.5% average weekly change). Shareholders have been diluted in the past year (2.2% increase in shares outstanding). Market cap is less than US$100m (NT$2.42b market cap, or US$77.0m). New Risk • Nov 20
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.2% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Earnings have declined by 48% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (2.2% increase in shares outstanding). Market cap is less than US$100m (NT$1.95b market cap, or US$61.6m). Reported Earnings • Aug 13
Second quarter 2023 earnings released: EPS: NT$0.01 (vs NT$0.26 loss in 2Q 2022) Second quarter 2023 results: EPS: NT$0.01 (up from NT$0.26 loss in 2Q 2022). Revenue: NT$103.8m (down 57% from 2Q 2022). Net income: NT$1.34m (up NT$37.4m from 2Q 2022). Profit margin: 1.3% (up from net loss in 2Q 2022). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance. Reported Earnings • Mar 22
Full year 2022 earnings released: NT$0.38 loss per share (vs NT$0.28 profit in FY 2021) Full year 2022 results: NT$0.38 loss per share (down from NT$0.28 profit in FY 2021). Revenue: NT$888.9m (up 26% from FY 2021). Net loss: NT$52.8m (down 246% from profit in FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance. Reported Earnings • Nov 16
Third quarter 2022 earnings released: NT$0.09 loss per share (vs NT$0.26 profit in 3Q 2021) Third quarter 2022 results: NT$0.09 loss per share (down from NT$0.26 profit in 3Q 2021). Revenue: NT$207.7m (down 17% from 3Q 2021). Net loss: NT$12.0m (down 134% from profit in 3Q 2021). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Nov 13
Third quarter 2022 earnings released: NT$0.09 loss per share (vs NT$0.26 profit in 3Q 2021) Third quarter 2022 results: NT$0.09 loss per share (down from NT$0.26 profit in 3Q 2021). Revenue: NT$207.7m (down 17% from 3Q 2021). Net loss: NT$12.0m (down 134% from profit in 3Q 2021). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. Reported Earnings • Aug 16
Second quarter 2022 earnings released: NT$0.26 loss per share (vs NT$0.021 profit in 2Q 2021) Second quarter 2022 results: NT$0.26 loss per share (down from NT$0.021 profit in 2Q 2021). Revenue: NT$241.2m (up 64% from 2Q 2021). Net loss: NT$36.0m (down NT$38.6m from profit in 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Upcoming Dividend • Jun 24
Upcoming dividend of NT$0.40 per share Eligible shareholders must have bought the stock before 01 July 2022. Payment date: 22 July 2022. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 3.1%. Lower than top quartile of Taiwanese dividend payers (6.4%). Lower than average of industry peers (7.0%). Reported Earnings • May 16
First quarter 2022 earnings released: EPS: NT$0.03 (vs NT$0.022 loss in 1Q 2021) First quarter 2022 results: EPS: NT$0.03 (up from NT$0.022 loss in 1Q 2021). Revenue: NT$257.6m (up 122% from 1Q 2021). Net income: NT$4.64m (up NT$7.27m from 1Q 2021). Profit margin: 1.8% (up from net loss in 1Q 2021). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Mar 17
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: NT$0.28 (up from NT$0.046 loss in FY 2020). Revenue: NT$706.3m (up 108% from FY 2020). Net income: NT$36.2m (up NT$41.6m from FY 2020). Profit margin: 5.1% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance. Reported Earnings • Nov 17
Third quarter 2021 earnings released: EPS NT$0.27 (vs NT$0.001 loss in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: NT$251.5m (up 217% from 3Q 2020). Net income: NT$35.7m (up NT$35.9m from 3Q 2020). Profit margin: 14% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 79 percentage points per year, which is a significant difference in performance. Upcoming Dividend • Nov 11
Upcoming dividend of NT$0.086 per share Eligible shareholders must have bought the stock before 18 November 2021. Payment date: 24 December 2021. Trailing yield: 0.6%. Lower than top quartile of Taiwanese dividend payers (5.2%). Lower than average of industry peers (2.8%). Reported Earnings • Aug 13
Second quarter 2021 earnings released: EPS NT$0.022 (vs NT$0.12 loss in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: NT$146.7m (up 422% from 2Q 2020). Net income: NT$2.56m (up NT$15.6m from 2Q 2020). Profit margin: 1.7% (up from net loss in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Reported Earnings • May 16
First quarter 2021 earnings released: NT$0.02 loss per share (vs NT$0.028 profit in 1Q 2020) The company reported a poor first quarter result with weaker earnings, revenues and control over costs. First quarter 2021 results: Revenue: NT$116.0m (down 26% from 1Q 2020). Net loss: NT$2.63m (down 183% from profit in 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Reported Earnings • Mar 31
Full year 2020 earnings released: NT$0.047 loss per share (vs NT$0.42 profit in FY 2019) The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2020 results: Revenue: NT$339.2m (down 53% from FY 2019). Net loss: NT$5.40m (down 111% from profit in FY 2019). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Annuncio • Mar 12
U-Best Innovative Technology Co., Ltd., Annual General Meeting, May 28, 2021 U-Best Innovative Technology Co., Ltd., Annual General Meeting, May 28, 2021. Is New 90 Day High Low • Jan 20
New 90-day low: NT$11.60 The company is down 9.0% from its price of NT$12.75 on 23 October 2020. The Taiwanese market is up 22% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period. Reported Earnings • Nov 14
Third quarter 2020 earnings released: NT$0.001 loss per share The company reported a poor third quarter result with weaker earnings, revenues and control over expenses. Third quarter 2020 results: Revenue: NT$79.2m (down 38% from 3Q 2019). Net loss: NT$165.0k (down 100% from profit in 3Q 2019). Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Is New 90 Day High Low • Oct 13
New 90-day low: NT$12.70 The company is down 15% from its price of NT$15.00 on 15 July 2020. The Taiwanese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period.